Psychostimulants such as methylphenidate have been used for depression in cancer patients. We report the successful use of methylphenidate to treat depression in 10 consecutive patients with advanced cancer. A rapid onset of effect was noted. Appetite, concentration, fatigue, and sedation also improved in some persons. No severe side effects were noted.
Holland J, Rowland J (eds): Handbook of Psychooncology. New York: Oxford University Press, 1998.
2.
Ng K, von Gunten CF: Symptoms and attitudes of 100 consecutive patients admitted to an acute hospice/palliative care unit. J Pain Symptom Manage. 1998; 16: 307-316.
3.
Martindale the extra pharmacopoeia, 31st ed.London, The Royal Pharmaceutical Society of Great Britain, 1996.
4.
Walsh D, Doona M, Molnar M, Lipnickey V: Symptom control in advanced cancer: important drugs and routes of administration. Semin Oncol. 2000; 27: 69-83.
5.
Fernandez F, Adams F, Holmes VF, et al.: Methyphenidate for depressive disorders in cancer patients. An alternative to standard antidepressants. Psychosomatics. 1987; 28:455-461.
Olin J, Massand P: Psychostimulants for depression in hospitalized cancer patients. Psychosomatics. 1996; 37: 57-62.
8.
Bruera E, Brenneis C, Paterson AH, MacDonald RN: Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage. 1989; 4: 3-6.
9.
Meyers CA, Weitzner MA, Valentine AD, Levin VA: Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998; 16: 2522-2527.
10.
Weitzner MA, Meyers CA, Valentine AD: Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. J Neuropsychiatry Clin Neurosci. 1995; 7: 347-350.
11.
Satel SL, Nelson JC: Stimulants in the treatment of depression: a critical overview. J Clin Psychiatry. 1989; 50: 241-249.
